Literature DB >> 973972

The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.

R Lancaster, T J Goodwin, W S Peart.   

Abstract

1 The effect of pindolol administered to twenty-six patients with hypertension of unknown origin was compared with respect to blood pressure and plasma renin activity change after increase of the dose over a period of 6 weeks. 2 There was no clear correlation between the fall of plasma renin activity, which in some patients was very marked, and the fall in blood pressure. Some patients with a fall in plasma renin activity did not drop their pressure. Conversely, some with a fall of pressure did not drop their plasma renin activity. 3 The addition of hydrochlorothiazide to the pindolol finally caused further lowering of the blood pressure in all but one patient and the plasma renin activity rose in all but two patinets. There was no clear correlation between change in plasma renin activity and the effect on blood pressure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973972      PMCID: PMC2958755          DOI: 10.1111/j.1365-2125.1976.tb00621.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.

Authors:  E L Bravo; R C Tarazi; H P Dustan
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

2.  Specificity of blockade of renal renin release by propranolol in the cat.

Authors:  E J Johns; B Singer
Journal:  Clin Sci Mol Med       Date:  1974-10

3.  Radioimmunoassay determination of plasma-renin activity.

Authors:  G W Boyd; A E Fitz; A R Adamson; W S Peart
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

4.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

Authors:  F R Bühler; J H Laragh; E D Vaughan; H R Brunner; H Gavras; L Baer
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

5.  Central hypotensive effect of propranolol in the rabbit.

Authors:  C T Dollery; P H Lewis; M G Myers; J L Reid
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

6.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

7.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

8.  The paradox of beta-adrenergic blockade in hypertension.

Authors:  E D Frohlich; R C Tarazi; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

9.  Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit.

Authors:  M A Weber; I R Thornell; G S Stokes
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

10.  Beta-blockers and plasma renin activity in hypertension.

Authors:  G S Stokes; M A Weber; I R Thornell
Journal:  Br Med J       Date:  1974-01-12
View more
  3 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.

Authors:  L Jordö; G Johnsson; P Lundborg; B A Persson; C G Regärdh; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.